Sun Pharmaceutical Industries: More special than others - Buy
The company's growth prospects are strong, driven by a pipeline of specialty launches25-08-2018
Sun Pharmaceutical Industries: More special than others - Buy
The company's growth prospects are strong, driven by a pipeline of specialty launchesNotice Of Book Closure And Details Of 26Th Annual General Meeting Of The Company For The Financial Year Ended March 31, 2018.
This is to inform you that the 26th Annual General Meeting of the shareholders of the Company would be held on Wednesday, September 26, 2018 at 02:45 p.m. at Crystal Hall, Grand Mercure Vadodara Surya Palace, Opposite Parsi Agyari, Sayajigunj, Vadodara - 390 020, Gujarat. Further, in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Register of Members...Sun Pharma: Consider bull-call spread strategy
The short-term outlook has turned positive for Sun Pharmaceutical Industries (623.50), which has been making consistent recovery after it touched aDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha ValiaDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Family Investment Pvt LtdStocks that saw rising operating profit margin growth, whose results released last one week: Sun Pharma, Indoco Remedies, Bharat Dynamics
As stock markets return to high levels, investors have been looking closely at the companies that performed well in recent results. Trendlyne's live results screeners track stock results as they come in, while looking for specific parameters. This stock screener for example (subscription required, but snapshot above) looks for stocks that have seen strong operating profit margin growth (above 15% YoY) in results, and announced results in the past one week. Sun Pharma made the cut on strong quarter performance for June, as did 37 other companies, including Bharat Dynamics and Sonata Software.Today's picks: From Sun Pharma to Vedanta, hot stocks to watch on Friday
For Sun Pharma, keep a stop at Rs 615 and go longAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to enclose herewith our Press Release relating to USFDA Approval of CEQUA, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you,Q1 results: Sun Pharma's US business peeps out from clouds
What is surprising is that despite the increase in sales in the US, Sun Pharma's gross margins have declined both from a year earlier and sequentiallyResults Update: Sun Pharma delivers a strong quarter performance, Shankar Builders, Cochin Shipyard announce results
The Results Dashboard, which updates results throughout the day, announced more thaan 200 results today. Among the big performers today was Sun Pharmaceuticals (which is in 12 stock screeners today), whose share price is rising on a bumper quarter performance. Net profits for the company stood at Rs 983 crore for the June quarter, compared with a loss of Rs 425 crore the same quarter last year, when the firm had to pay settlements of Rs. 951 crore in an US antitrust case. Shankara Building Projects also rose in share price after it announced revenue growth of 32.7% YoY of and net profit growth of over 13% YoY. Cochin Shipyard announced double digit growth in revenues and net profits for the June quarter, but missed estimates. For the full dashboard, click here.